Tamarly Intelligence
Deal · Completed

Dalian Wanchunbulin Pharmaceuticals Ltd. and Assets sold by BeyondSpring Inc.

First filed 6 Oct 2026, 1 filing.

The deal
Buyer
Dalian Wanchunbulin Pharmaceuticals Ltd.
Target
Assets sold by BeyondSpring Inc.
Seller
BeyondSpring Inc.
Status
Completed
Region
US
On September 30, 2026, BeyondSpring Inc.

Source: The filing (SEC Form 8-K)

With a free account

A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.